Docetaxel in combination with Temsirolimus in patients with advanced castration resistant prostate cancer (CRPC): A phase II trial of the Spanish Oncology Genitourinary Group
Data de publicación
2013Título da revista
EUROPEAN JOURNAL OF CANCER
Tipo de contido
Publicación de congreso